Allogeneic transplantation for adult T-cell leukemia/lymphoma in adolescent and young adults and young patients: A nationwide retrospective study by the ATL working group of the Japan society for transplantation and cellular therapy.

Autor: Itonaga H; Transfusion and Cell Therapy Unit, Nagasaki University Hospital, Nagasaki, Japan., Fukushima T; Laboratory of Hematoimmunology, Graduate School of Health Sciences, University of the Ryukyus, Nishihara, Japan., Kato K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan., Nakano N; Department of Hematology, Imamura General Hospital, Kagoshima, Japan., Kato T; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan., Tanaka T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan., Eto T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan., Mori Y; Hematology, Oncology & Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan., Kawakita T; Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan., Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan., Fujioka M; Department of Hematology, Sasebo City General Hospital, Sasebo, Japan., Nakamae H; Department of Hematology, Osaka Metropolitan University Hospital, Osaka, Japan., Ogata M; Department of Hematology, Oita University Hospital, Oita, Japan., Morishima S; Division of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology, Second Department of Medicine, Graduate School of Medicine, University of the Ryukyus Hospital, Nishihara, Japan., Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan., Kanda Y; Division of Hematology, Jichi Medical University, Shimotsuke, Japan., Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan.; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan., Fuji S; Department of Hematology, Osaka International Cancer Center Institute, Osaka, Japan., Yoshimitsu M; Department of Hematology and Immunology, Kagoshima University Hospital, Kagoshima, Japan.

Publikováno v: Hematological oncology [Hematol Oncol] 2024 Nov; Vol. 42 (6), pp. e3315.

Bayesian sparse regression for exposure-response analyses of efficacy and safety endpoints to justify the clinical dose of valemetostat for adult T-cell leukemia/lymphoma.

Autor: Fukae M; Daiichi Sankyo Co., Ltd., Tokyo, Japan., Rogers J; Metrum Research Group, Tariffville, Connecticut, USA., Garcia R; Metrum Research Group, Tariffville, Connecticut, USA., Tachibana M; Daiichi Sankyo Co., Ltd., Tokyo, Japan., Shimizu T; Daiichi Sankyo Co., Ltd., Tokyo, Japan.

Publikováno v: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Oct; Vol. 13 (10), pp. 1655-1669. Date of Electronic Publication: 2024 Aug 18.

Chidamide combined with a modified Bu-Cy conditioning regimen improves survival in patients with T-cell acute lymphoblastic leukemia/lymphoma undergoing allogeneic hematopoietic stem cell transplantation.

Autor: Cao X; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China., Li Z; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China., Zhang Y; Department of Hematology, Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, China., Cui Q; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China., Dai H; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China., Ma Y; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China., Li M; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China., Chen S; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China., Yin J; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China., Cui W; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China., Chen J; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China., Sun A; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China., Qiu H; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China., Chen S; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China., Zhu X; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China., Andersson BS; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Wu D; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China. drwudepei@163.com.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. drwudepei@163.com., Tang X; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China. xwtang1020@163.com.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. xwtang1020@163.com.

Publikováno v: Annals of hematology [Ann Hematol] 2024 Aug; Vol. 103 (8), pp. 3083-3093. Date of Electronic Publication: 2024 Jun 20.

Efficacy of blinatumomab as maintenance therapy for B-lineage acute lymphoblastic leukemia/lymphoma following allogeneic hematopoietic cell transplantation.

Autor: Huang J; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.; Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China., Shi B; Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China., Yu S; Department of Hematology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200136, China., Xue M; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, 215006, China., Wang L; Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.; Department of Hematology, Shanghai Institute of Hematology, Blood and Marrow Transplantation Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China., Jiang J; Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.; Department of Hematology, Shanghai Institute of Hematology, Blood and Marrow Transplantation Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China., Hu J; Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.; Department of Hematology, Shanghai Institute of Hematology, Blood and Marrow Transplantation Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China., Zhu J; GoBroad Medical Institute of Hematology (Shanghai Center), Liquan Hospital, Shanghai, 200433, China., Chen S; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, 215006, China. chensuning@sina.com., Shen L; Department of Hematology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200136, China. shenlijing@renji.com., Cao W; Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China. caoweijie2003@126.com., Cao Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. caoyangemma@163.com., Hu X; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. hu_xiaoxia@126.com.; Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. hu_xiaoxia@126.com.

Publikováno v: Blood cancer journal [Blood Cancer J] 2024 Jul 08; Vol. 14 (1), pp. 109. Date of Electronic Publication: 2024 Jul 08.

Flow cytometry for meningeal infiltration in B acute lymphoblastic leukemia in a low middle income country.

Autor: Anane E; Biological hematology department, Aziza Othmana University Hospital, Tunis, Tunisia.; Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia., Lakhal FB; Biological hematology department, Aziza Othmana University Hospital, Tunis, Tunisia.; Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia., Salem SF; Biological hematology department, Aziza Othmana University Hospital, Tunis, Tunisia., Ghali O; Biological hematology department, Aziza Othmana University Hospital, Tunis, Tunisia.; Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia., Feki E; Biological hematology department, Aziza Othmana University Hospital, Tunis, Tunisia., Abdennebi YB; Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia.; Department of Hematology, Aziza Othmana University Hospital, Tunis, Tunisia., Bahri M; Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia.; Department of Hematology, Aziza Othmana University Hospital, Tunis, Tunisia., Azza E; Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia.; Department of Hematology, Aziza Othmana University Hospital, Tunis, Tunisia., Aissaoui L; Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia.; Department of Hematology, Aziza Othmana University Hospital, Tunis, Tunisia., El Borgi W; Biological hematology department, Aziza Othmana University Hospital, Tunis, Tunisia.; Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia., Gouider E; Biological hematology department, Aziza Othmana University Hospital, Tunis, Tunisia.; Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia.

Publikováno v: Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2024 Sep; Vol. 106 (5), pp. 405-411. Date of Electronic Publication: 2024 May 06.